Background: Robotic hepatectomy represents an appealing treatment modality for resectable hepatocellular carcinoma (HCC). A contemporary review of robotic hepatectomy compared to laparoscopic/open hepatectomy is necessary.Methods: We performed a literature review to identify studies between 2018–2024 comparing robotic to laparoscopic/open hepatectomy for HCC with measurable outcomes.Results: A total of 10 studies were identified, including 943 patients undergoing robotic hepatectomy compared to 1678 patients undergoing laparoscopic/open hepatectomy. Generally, while similar short/long-term survival was noted across all resection modalities, robotic hepatectomy was associated with longer operative time, shorter length of stay, and less post-operative complications. An additional 4 studies were evaluated in the context of HCC, reviewing the prognostic value of robotic hepatectomy margins, robotic hepatectomy in the context of metabolic syndrome, “huge” (>10 cm) HCCs, and robotic hepatectomy vs. microwave ablation.Conclusions: Robotic hepatectomy is a safe alternative to laparoscopic/open hepatectomy for HCC that provides similar oncological/long-term outcomes, while potentially decreasing post-operative complications and length of stay.
背景：机器人肝切除术是可切除肝细胞癌（HCC）的一种具有吸引力的治疗方式。有必要对机器人肝切除术与腹腔镜/开腹肝切除术进行当代综述比较。 方法：我们进行了文献综述，筛选出2018年至2024年间比较机器人肝切除术与腹腔镜/开腹肝切除术治疗HCC并报告可测量结局的研究。 结果：共纳入10项研究，包括943例接受机器人肝切除术的患者与1678例接受腹腔镜/开腹肝切除术的患者。总体而言，尽管所有切除方式均显示出相似的短期/长期生存率，但机器人肝切除术与更长的手术时间、更短的住院时间及更少的术后并发症相关。另有4项研究在HCC背景下进行了评估，分别探讨了机器人肝切除术切缘的预后价值、代谢综合征背景下机器人肝切除术的应用、治疗"巨大"（>10 cm）HCC以及机器人肝切除术与微波消融的对比。 结论：对于HCC，机器人肝切除术是腹腔镜/开腹肝切除术的安全替代方案，能提供相似的肿瘤学/长期结局，同时可能减少术后并发症并缩短住院时间。
A Contemporary Review of Robotic Resection for Hepatocellular Carcinoma
肿瘤(癌症)患者之家